نتایج جستجو برای: capital cost

تعداد نتایج: 461126  

2013
Kevin E. Dow Jie Yu Vincent J. Shea

The cost of equity capital has been an important topic to both academics and practitioners. In this study, we examine the effect information technology (IT) intensity on the industry cost of equity capital. Findings generally support the idea that IT intensity is a significant factor driving industry cost of equity capital. Further, an interaction between IT intensity and time suggests that IT ...

هدف مقاله حاضر بررسی تأثیر افشای سرمایه اجتماعی بر هزینه سرمایه در شرکت‌های با عدم تقارن اطلاعاتی می‌باشد. در این راستا تعداد 110 شرکت پذیرفته شده در بورس اوراق بهادار تهران با استفاده از روش نمونه‌گیری حذفی انتخاب گردید. برای اندازه‌گیری افشای سرمایه اجتماعی از سه شاخص سرمایه شناختی، سرمایه ساختاری و سرمایه رابطه‌ای و برای سنجش عدم تقارن اطلاعاتی از شاخص هزینه تبلیغات استفاده شده است. از روش د...

2012
Kuo-Lung Hou Li-Chiao Lin

In this paper, the study attempts to determine the optimal capital investment in setup cost reduction and optimal lot sizing policies for an economic order quantity (EOQ) model with random yields. The setup cost is treated as the function of capital expenditure in technology. The study shows that the expected total annual cost functions with capital investment is convex and develop a solution p...

Journal: :ارتقای ایمنی و پیشگیری از مصدومیتها 0
الهه عینی elaheh ainy دانشگاه علوم پزشکی شهید بهشتیسازمان اصلی تایید شده: دانشگاه علوم پزشکی شهید بهشتی (shahid beheshti university of medical sciences) حمید سوری hamid soori دانشگاه علوم پزشکی شهید بهشتیسازمان اصلی تایید شده: دانشگاه علوم پزشکی شهید بهشتی (shahid beheshti university of medical sciences)

background and objective : to resource allocating at national levels as results of productivity, cost calculation helps to determine the size of the problem and revealed cost benefits of injury prevention and it can also ensure the better resource using and cost benefit assessment. this study was conducted to determine the method of calculating road traffic injuries cost. materials and methods:...

2004
PAUL HRIBAR

This paper examines the effect of accounting restatements on a firm’s cost of equity capital. We show that, on average, accounting restatements lead to both decreases in expected future earnings and increases in the firm’s cost of equity capital. Depending on the model used, relative percentage increases in the cost of equity capital average between 7 and 19% in the month immediately following ...

2015
William R. Cline

Some advocates of far higher capital requirements for banks invoke the Modigliani-Miller theorem as grounds for judging that associated costs would be minimal. The M&M theorem holds that the average cost of capital to the firm is independent of capital structure, because any reduction in capital cost from switching to higher leverage using lowercost debt is exactly offset by an induced increase...

Akram Khani Farahani, Ali Mohades Majid Sheshmani

The purpose of this study was to examine the expected returns of Carhart model compared to the capital asset pricing model and the implicit capital cost model based on cash and capital returns of growth and value stocks. The statistical population consisted of the companies listed in Tehran Stock Exchange and the time domain is between 2007 and 2016. By choosing Cochran sampling, 126 companies ...

2008
Zhihong Chen Dan S. Dhaliwal

Regulation Fair Disclosure (Reg FD) prohibits selective disclosure of material information to a subset of market participants such as analysts and institutional investors without simultaneously disclosing the same information to the investing public. We examine the effect of Reg FD on the cost of equity capital. If Reg FD curtails selective disclosure without a significant adverse effect on the...

2015
Ayman Chit Ahmad Chit Manny Papadimitropoulos Murray Krahn Jayson Parker Paul Grootendorst

The opportunity cost of the capital invested in pharmaceutical research and development (R&D) to bring a new drug to market makes up as much as half the total cost. However, the literature on the cost of pharmaceutical R&D is mixed on how, exactly, one should calculate this "hidden" cost. Some authors attempt to adopt models from the field of finance, whereas other prominent authors dismiss thi...

2005
Tim Baldenius Sunil Dutta Stefan Reichelstein

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید